Market Cap (In TWD)
1.62 Billion
Revenue (In TWD)
720.43 Million
Net Income (In TWD)
97.41 Million
Avg. Volume
52.6 Thousand
- Currency
- TWD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 13.5-18.35
- PE
- -
- EPS
- -
- Beta Value
- -0.031
- ISIN
- TW0001780005
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Qing Hui Lin
- Employee Count
- -
- Website
- https://www.altratene.com
- Ipo Date
- 2012-06-20
- Details
- Allied Biotech Corporation manufactures and sells carotenoids worldwide. Its products include Beta-Carotene that offers yellow to reddish orange shades to appeal color in various applications; Beta-Apo-8'-Carotenal, which is used as a food colorant, and provides a range of orange to red shades; and Lycopene, which offers a range of red shades as a nutrient for food, dietary supplements, and pharmaceutical products. The company also provides Canthaxanthin, which offers a range of shades of reddish orange for food and beverage applications; Lutein, a carotenoid that provides a range of green leafed vegetables, such as spinach, kale, broccoli, and egg yolks.; and Nano Coenzyme Q10, an antioxidant, which is used in the transformation of energy in the body. It serves food, beverage, dietary supplement, and feed industries. Allied Biotech Corporation was founded in 2001 and is headquartered in Taipei, Taiwan.
More Stocks
-
LPX
-
4242
-
AVIAVI Limited
AVI
-
3694OPTiM Corporation
3694
-
ARYCArrayit Corporation
ARYC
-
BAKKBakkavor Group plc
BAKK
-
DAWN
-
RNK